Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

decitabine

decitabine
  • Restricted Anti-Neoplastic Formulary
  • Restricted Dacogen --> Restricted to hematology-oncology use. Patients should have tried other available therapies before receiving decitabine.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dacogen POWDER FOR INJECTION, INTRAVENOUS 50 mg      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

 

Formulary status is restricted to hematology-oncology use. Patients should have tried other available therapies before receiving decitabine.

Reviewed: June 27, 2006

Last updated: Apr. 11, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved